Featured Research

from universities, journals, and other organizations

Doppler ultrasound in pregnancy reduces risk in high-risk groups

Date:
January 22, 2010
Source:
Wiley-Blackwell
Summary:
Current evidence suggests that using Doppler ultrasound in high-risk pregnancies to monitor a fetus' health may reduce caesarean sections and the number of babies who die, according to a new review.

Current evidence suggests that using Doppler ultrasound in high-risk pregnancies to monitor a fetus' health may reduce caesarean sections and the number of babies who die, according to a new Cochrane Systematic Review.

Doppler ultrasound is a well established technique used to diagnose problems during pregnancy. In the same way that a speed radar measures how fast cars are travelling, Doppler ultrasound can monitor how fast blood is moving in the umbilical blood flow. Professionals can then look to see whether the blood flow is normal, indicating that the fetus is healthy, or abnormal, indicating that the fetus is under stress. The health professionals can then decide which high-risk pregnancies need assistance in delivering the baby, and which women can be left to deliver without assistance.

The aim of using Doppler is to reduce risk to the baby. However, some experts argue that it may prompt some unnecessary early interventions.

The review included 18 studies which together included 10,000 women in "high risk" groups. High risk women included those who had previously lost babies during pregnancy, those carrying growth restricted babies and women with hypertension or diabetes. Women who were examined with Doppler ultrasound were compared with those who had no Doppler or with those who had cardiotocography (CTG), which monitors the baby's heartbeat. According to the results, Doppler reduced infant deaths, possibly through better timing of caesarean sections, as well as reducing the number of caesarean sections themselves, and inductions of labour. However, the researchers say the studies included were of questionable quality.

"A case could certainly be made for a higher quality, multi-centre trial of Doppler ultrasound than we have so far seen," said lead researcher Zarko Alfirevic, who is based at the Division of Perinatal and Reproductive Medicine at the University of Liverpool. "It is quite possible that for some so-called high risk groups fetal Doppler offers little or no benefit. Women with diabetes are one such group where fetal Doppler may, in fact, give false reassurance.

"It is important to point out, of course, that it is the clinical decision that follows a Doppler ultrasound examination that changes the outcome for the baby, and currently there is little agreement on what intervention should follow an abnormal Doppler finding."

Work on this review was supported by a grant from the National Institute for Health Research (NIHR), UK.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Doppler ultrasound in pregnancy reduces risk in high-risk groups." ScienceDaily. ScienceDaily, 22 January 2010. <www.sciencedaily.com/releases/2010/01/100119213045.htm>.
Wiley-Blackwell. (2010, January 22). Doppler ultrasound in pregnancy reduces risk in high-risk groups. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/01/100119213045.htm
Wiley-Blackwell. "Doppler ultrasound in pregnancy reduces risk in high-risk groups." ScienceDaily. www.sciencedaily.com/releases/2010/01/100119213045.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins